title: [Why heart failure clinics?].
authors.forename: Martin
authors.initials: M
authors.lastname: Hülsmann
authors.forename: Richard
authors.initials: R
authors.lastname: Pacher
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001317:Austria; D002300:Cardiac Care Facilities / Q000191:economics; D003325:Coronary Care Units; D003365:Costs and Cost Analysis; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D006439:Hemodynamics; D006760:Hospitalization; D006801:Humans; D008019:Life Style; D011379:Prognosis; D011788:Quality of Life; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D004232:Diuretics